Trofinetide for the Treatment of Girls Aged Two to Four Years with Rett Syndrome: Final Results from the Open-label DAFFODIL Study (S37.003)

To investigate the safety/tolerability and exploratory efficacy of long-term treatment with trofinetide in girls aged 2–4 years with Rett syndrome (RTT).